[Data for the substantiation of the maximum permissible exposure level of armos fiber dust in the air of the work area]. / Materialy k obosnovaniiu PDK pyli volokna armos v vozdukhe rabochei zony.

The 'Armos' fibre dusts are characterized by low cytotoxicity, absence of fibrogenicity, display non-toxic properties in single exposures with no skin-irritating and sensibilizing effects. In repeated introduction into the stomach, the trachea, and if inhaled, these dusts displayed weak toxic properties. Dust concentrations at 10 mg/m3 are in proximity to the threshold one. The MAC for 'Armos' dusts in working zone areas was recommended at 5 mg/m3 (4th class of hazardness).

[Clinical use of tramal in patients in the early postoperative period]. / Klinicheskoe primenenie tramala u bol'nykh v rannem posleoperatsionnom periode.

Tramal was given to 204 patients who were operated on the lung, heart, abdomen. During pain therapy, good and satisfactory results were on average obtained in 75% patients operated on the lung, in 77%, on the heart, in 89%, on the abdomen, in 70%, on the great vessels. The absence of the inhibitory effect of the drug on the respiratory center and its slightly marked sedative effect allow one to recommend the agent for application in the early period following the surgery when narcotic analgesics still retain their effect and a real risk of their overdosage exists. During prolonged artificial pulmonary ventilation in the early postoperative period and in impaired adaptation of the patients to a respirator, tramal aids normalization of lung mechanics and hemodynamic parameters without eliminating and suppressing the patients' consciousness and results in cessation of muscular shivering. Adverse effects of tramal are of no decisive clinical significance and occur mainly when the drug is rapidly injected into the vein.